News Quantified

EW – edwards lifesciences corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities [Yahoo! Finance]

New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients

Jim Cramer Calls Edwards Lifesciences (EW) a Hold – Prefers Boston Scientific Right Now! [Yahoo! Finance]

Peijia Medical Announces 2024 Annual Results [Yahoo! Finance]

Capstan brings surgical robot to valve replacement [Yahoo! Finance]

6.6%

BEAT

6.6%

BEAT

6.6%

BEAT

6.6%

BEAT

Canaccord Genuity

Form 4 Edwards Lifesciences For: Mar 26 Filed by: Ullem Scott B.

Form ARS Edwards Lifesciences For: Dec 31

Form DEFA14A Edwards Lifesciences

Form DEF 14A Edwards Lifesciences For: Dec 31

Form DEFA14A Edwards Lifesciences

Top News Gainers

3/23 Form 4 Edwards Lifesciences For: Mar 23 Filed by: Szyman Catherine M. 17.6%

7/23 Q2/2019 6/30/2019 EPS 1.380 ZacksConsensus 1.320 ActVsEst 0.060 - Beat 9.8%

4/1 Form 4 Edwards Lifesciences For: Apr 01 Filed by: Lemercier Jean-Luc M 6.9%

3/9 Form 4 Edwards Lifesciences For: Mar 06 Filed by: BOBO DONALD E JR 6.2%

4/16 Form 4 Edwards Lifesciences For: Apr 16 Filed by: Szyman Catherine M. 5.0%

4/13 Form DEFA14A Edwards Lifesciences 4.9%

3/25 Form DEFA14A Edwards Lifesciences 4.5%

4/9 Edwards Lifesciences Corp (NYSE: EW) had its price target lowered by analysts at Raymond James from $263.00 to $230.00. They now have an "outperform" rating on the stock. 4.1%

10/25 Form 10-Q Edwards Lifesciences For: Sep 30 4.0%

2/3 Form 4 Edwards Lifesciences For: Feb 03 Filed by: Lemercier Jean-Luc M 3.7%

Top News Decliners

1/30 Form 8-K Edwards Lifesciences For: Jan 30 -10.6%

4/24 Edwards Lifesciences Corp (NYSE: EW) had its "buy" rating re-affirmed by analysts at Citigroup Inc. They now have a $255.00 price target on the stock, up previously from $240.00. -5.7%

3/20 Form 4 Edwards Lifesciences For: Mar 19 Filed by: MUSSALLEM MICHAEL A -5.1%

4/27 Edwards Lifesciences Corp (NYSE: EW) had its "underweight" rating re-affirmed by analysts at Barclays PLC. They now have a $155.00 price target on the stock, down previously from $165.00. -5.0%

10/24 Edwards Lifesciences Corp (NYSE: EW) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $255.00 price target on the stock, up previously from $240.00. -4.0%

4/28 Edwards Lifesciences Corp (NYSE: EW) was downgraded by analysts at Wells Fargo & Co from an "overweight" rating to an "equal weight" rating. -3.5%

4/30 Form 4 Edwards Lifesciences For: Apr 30 Filed by: Szyman Catherine M. -3.1%

3/30 Form 4 Edwards Lifesciences For: Mar 30 Filed by: WANG HUIMIN -3.0%

9/6 Form 4 Edwards Lifesciences For: Sep 06 Filed by: BOBO DONALD E JR -2.7%

3/2 Form 4 Edwards Lifesciences For: Mar 02 Filed by: Wood Larry L -2.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day